Physician profile
Beth E Benson
NPI 1205811197
$980.24
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $304 · 2020: $57.17 · 2021: $320 · 2022: $299.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $215.29 | 2019-2022 | |
| Myovant Sciences INC. | $173.60 | 2021-2022 | |
| Mayne Pharma Commercial LLC | $137.41 | 2022 | |
| Aspira Women'S Health INC | $103.06 | 2019 | |
| Intuitive Surgical, INC. | $97.67 | 2022 | |
| Exeltis, USA INC. | $81.96 | 2021 | |
| Pfizer INC. | $48.07 | 2019-2022 | |
| Therapeuticsmd, INC. | $26.91 | 2019-2021 | |
| Allergan, INC. | $23.86 | 2020 | |
| Vertical Pharmaceuticals, LLC | $18.31 | 2020 | |
| Evofem Biosciences, INC. | $15.39 | 2021 | |
| Amgen INC. | $14.34 | 2019 | |
| Merck Sharp & Dohme LLC | $12.41 | 2019 | |
| Lupin INC. | $11.96 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Beth Benson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.